Park 4MEDi - Biotech Business Park for Medical Innovations, located in Ostrava, represents one of the worldwide leading hi-tech centres for biomedical research and development of new processes and medicinal products in the field of Advanced Therapy.
4MEDi, which is to be operated by a PrimeCell Therapeutics Inc. subsidiary, namely, Center for Cell Therapy and Diagnostics Inc. is currently under construction. Located within the promises of the University Hospital Ostrava, the centre is designed to cover almost 6500 m2.
Biotech park 4MEDi represents a significant infrastructure for the global Advanced Therapy Medicinal Products (ATMPs) market. The centre is to provide the latest technologies for testing, diagnostics, development and clinical research of ATMPs.
ATMPs are new unique medicinal products, based on human cells and tissues, which are designed to save, prolong or to significantly improve quality of people´s life. ATMPs offer new opportunities to treat incurable diseases or injuries, such as severe cardiovascular disease, ischemic diseases, cancer, degenerative diseases and other serious illnesses.
The production capacity of 4MEDi is planned to meet the global rapid growing demand of patients for unique cell-based medicinal products.
The major scientific partners of the new state-of-the-art centre, which is designed to enlarge the market´s needed capacity for development and production of ATMPs, are the University Hospital Ostrava and the Medical Institute in Ostrava.